Northfield Laboratories Presentation at the BIO CEO & Investor Conference to be Webcast Live

EVANSTON, Ill., Feb. 8  /PRNewswire-FirstCall/ -- Northfield Laboratories Inc. (NASDAQ:NFLD) announced today that Steven A. Gould, M.D., Chairman and Chief Executive Officer, will be presenting at the BIO CEO & Investor Conference on February 15, 2006 at 1:15 p.m. E.T.

Interested investors may access the live webcast of the presentation at http://www.northfieldlabs.com/. A replay of the presentation will be available and will be archived for two weeks.

About Northfield Laboratories

Northfield Laboratories Inc. is a leader in developing an oxygen-carrying resuscitative fluid, PolyHeme(R), for the treatment of urgent, large volume blood loss in trauma and resultant surgical settings. PolyHeme(R) is a solution of chemically modified human hemoglobin that requires no cross matching and is therefore compatible with all blood types. It has a shelf life in excess of 12 months. Enrollment is currently underway in a pivotal Phase III trial of PolyHeme(R) beginning in the pre-hospital setting. For further information, visit http://www.northfieldlabs.com/.

  FOR FURTHER INFORMATION CONTACT:
  Sophia H. Twaddell
  Vice President, Corporate Communications
  [phone]
  

  Sharon L. Weinstein
  Director, Investor Relations
  Noonan Russo
  [phone]
  

First Call Analyst: 

FCMN Contact: [e-mail] 

DATASOURCE: Northfield Laboratories Inc.



CONTACT:  Sophia H. Twaddell, Vice President, Corporate Communications of

Northfield Laboratories Inc., [phone], ;

Sharon L. Weinstein, Director, Investor Relations, Noonan Russo,

[phone], , for Northfield Laboratories

Inc.



Web site:  http://www.northfieldlabs.com/ 

Copyright